SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-24-013689
Filing Date
2024-02-14
Accepted
2024-02-14 09:30:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea193683-13gjp_elevai.htm SC 13G 31918
  Complete submission text file 0001213900-24-013689.txt   33575
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 18667944940
Elevai Labs Inc. (Subject) CIK: 0001840563 (see all company filings)

IRS No.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94408 | Film No.: 24633119
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2615 Q STREET, #1 SACRAMENTO CA 95816
Business Address 2615 Q STREET, #1 SACRAMENTO CA 95816 866-794-4940
JP Bio Consulting LLC (Filed by) CIK: 0002003776 (see all company filings)

IRS No.: 851618883 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G